We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Acute diarrhea
From WikEM
Contents
- 1 Background
- 2 Clinical Features
- 3 Differential Diagnosis
- 4 Evaluation
- 5 Supportive Therapies
- 6 Antibiotics for Infectious Diarrhea
- 6.1 Relative Indications for Antibiotics[4]
- 6.2 Empiric Therapy
- 6.3 Traveler's Diarrhea
- 6.4 Clostridium difficile
- 6.5 Campylobacter jejuni
- 6.6 Entamoeba Histolytica
- 6.7 Giardia lamblia
- 6.8 Microsporidium
- 6.9 Cryptosporidium
- 6.10 Salmonella (non typhoid)
- 6.11 Shigella
- 6.12 Vibrio Cholerae
- 6.13 Yersinia enterocolitica
- 7 Disposition
- 8 See Also
- 9 References
Background
- Almost all true diarrheal emergencies are of noninfectious origin
- 85% of diarrhea is infectious in etiology
- Viruses cause vast majority of infectious diarrhea
- Bacterial causes are responsible for most cases of severe diarrhea
- Foreign travel associated with 80% probability of bacterial diarrhea (see Traveler's Diarrhea)
Definitions
- Diarrhea: Increased frequency of defection, usually >3 bowel movements per day
- Hyperacute: 1-6 hr
- Acute: less than 3 wks in duration
- Gastroenteritis: Diarrhea with nausea and/or vomiting
- Dysentery: Diarrhea with blood/mucus/pus
- Invasive = Infectious
Clinical Features
History
- Possible food poisoning?
- Symptoms occur within 6hr
- Does it resolve (osmotic) or persist (secretory) with fasting?
- Are the stools of smaller volume (large intestine) or larger volume (small intestine)
- Fever or abdominal pain? (diverticulitis, gastroenteritis, IBD)
- Bloody or melenic?
- Tenesmus? (shigella)
- Malodorous? (giardia)
- Recent travel? (Traveler's Diarrhea)
- Recent antibiotics? (C. diff)
- HIV/immunocompromised/high risk behaviors?
- Heat intolerance and anxiety? (thyrotoxicosis)
- Paresthesias or reverse temperature sensation? (Ciguatera)
Physical Exam
- Thyroid masses
- Oral ulcers, erythema nodosum, episcleritis, anal fissure (IBD)
- Reactive arthritis (Arthritis, conjunctivitis, urethritis)
- Suggests infection with salmonella, shigella, campylobacter, or yersinia
- Rectal exam for fecal impaction
- Guaiac
- Abdominal pain out of proportion to exam (mesenteric ischemia)
Differential Diagnosis
Acute diarrhea
Infectious
- Viral (e.g. rotavirus)
- Bacterial
- Campylobacter
- Shigella
- Salmonella (nontyphi)
- Escherichia coli
- E. coli 0157:H7
- Yersinia enterocolitica
- Vibrio cholerae
- Clostridium difficile
- Parasitic
- Toxin
Noninfectious
- GI Bleed
- Appendicitis
- Mesenteric Ischemia
- Diverticulitis
- Adrenal Crisis
- Thyroid Storm
- Toxicologic exposures
- Antibiotic or drug-associated
Watery Diarrhea
- Enterotoxigenic E. coli (most common cause of watery diarrhea)[1]
- Norovirus (often has prominent vomiting)
- Campylobacter
- Non-typhoidal Salmonella
- Enteroaggregative E. coli (EAEC)
- Enterotoxigenic Bacteroides fragilis
Traveler's Diarrhea
Evaluation
Toxigenic v. Infectious
Characteristic | Toxic | Infectious/Invasive |
Incubation | 2-12h | 1-3d |
Onset | abrupt | gradual |
Duration | <10-24h | 1-7days |
Fever | No | Yes |
Abdominal Pain | Minimal | Yes, tenesmus |
Systemic | No | Yes, myalgias, nausea and vomiting |
Physical findings | Nontoxic | Toxic |
Abdominal Tenderness | No | Yes |
Stool Blood, WBCs | No | Yes |
Indications for Workup
Indicated for:
- Profuse watery diarrhea with signs of hypovolemia
- Severe abdominal pain
- Fever >38.5 (101.3) (suggests infection with invasive bacteria)
- Symptoms >2-3d
- Blood or pus in stool (E. coli 0157:H7)
- Recent hospitalization or antibiotic use
- Elderly or immunocompromised
- Systemic illness with diarrhea (esp if pregnant (listeria))
Stool Studies
Fecal leukocytes
- Used to differentiate invasive from noninvasive infectious diarrheas
- Sn 50-80%, Sp 83% for presence of bacterial pathogen
- If patient has +leukocytes but negative infection consider IBD
Stool culture
- Plays minor role in ED evaluation
- Yield is only 1.5-5.5%
- Consider in patients with
- Immunosuppression
- Severe, inflammatory diarrhea (including bloody diarrhea)
- Underlying IBD (need to distinguish between flare and superimposed infection)
O&P
- Indicated if parasitic cause is suspected:
C. diff toxin
- 10% false negative rate
- Takes 24hr to run
Chemistry
- Warranted in severely dehydrated patients
Abdominal X-ray
- Consider if history of abdominal symptoms (rule out obstruction)
Chest Xray
- Consider if diarrhea + cough (Legionella)
CT
- Consider if suspect mesenteric ischemia
Supportive Therapies
Oral rehydration
- Fluids should contain sugar, salt, and water
Probiotics
- Lactobacilli and bifidobacterium
- 25% decrease in average duration of diarrhea (good evidence)
Diet Modification
- Eat: BRAT(Bananas, Rice, Applesauce and Toast) diet (no evidence)
- Avoid: Caffeine (increased gastric motility), raw fruit (increased osmotic diarrhea), lactose
Bismuth subsalicylate
- Consider when loperamide is contraindicated (high fever, dysentery)
- Dose: 30 mL or 2tab q30 min for 8doses; repeat on day 2
- Caution: may cause bismuth encephalopathy in HIV patients
Diphenoxylate and atropine
- Dose: 4mg QID x2d
- 2nd line agent (may cause cholinergic side effects)
Antibiotics for Infectious Diarrhea
- Most cases of diarrhea are not from infectious causes. If the patient suspects that there is blood in the stool but there is no abdominal pain, and no fever, the cause is unlikely to be from a bacterial cause. Also avoid antibiotics in E. Coli 0157:H7 (EHEC) cases due the risk of Hemolytic Uremic Syndrome (HUS)[2]
- The majority of patients, even with bacterial positive cultures, will recover from diarrhea illness without antibiotic therapy[3]
Relative Indications for Antibiotics[4]
- Suspected bacterial diarrhea
- Bloody diarrhea (except for EHEC) with fever and systemic illness
- Occult blood or +fecal leukocytes
- Moderate to severe travelers' diarrhea (>4 stools/d, fever, blood, or mucus in stool)
- >8 stools/d
- Volume depletion
- >1wk duration
- Immunocompromised
- Toxic appearance
Empiric Therapy
- Ciprofloxacin 500mg PO BID x 5 days OR
- Levofloxacin 599mg PO once daily x 5 days OR
- TMP/SMX 1 DS tablet PO BID x 5 days
Traveler's Diarrhea
- Therapy should be based on the geography of travel
Adult Options:
- Ciprofloxacin 750mg PO once daily x 1-3 days[5]
- First choice for use except in South and Southeast Asia[6]
- Azithromycin 500mg PO q24h x 3 days OR 1000mg PO x 1[7]
- Rifaximin 200mg PO TID x 3 days[10]
- Ineffective against mucosally invasive pathogens (Shigella, Salmonella, Campylobacter)
- Considered very safe as it is not absorbed
Pediatric Options:
- Avoid fluroquinolones
- Azithromycin 10mg/kg/day once daily x 3 days OR[11]
- Ceftriaxone 50mg/kg/day once daily x 3 days
Clostridium difficile
- Vancomycin 125-250mg PO q6hr x10d (IV form is not effective)
- Add Metronidazole 500mg IV q6hr if ileus or patient cannot tolerate PO
Campylobacter jejuni
- Erythromycin 500mg PO BID x 5 days
- Ciprofloxacin 500mg PO BID x 5 days OR
- Azithromycin 500mg PO once daily x 5 days
Entamoeba Histolytica
- Metronidazole 750mg PO three times daily for 5-10 days PLUS
- Paromomycin 500mg q8hrs for 7 days OR
- Iodoquinol 650mg q 8hrs daily 20 days
Giardia lamblia
- Metronidazole 250mg PO q8hrs for 7-10days
- Tinidazole 2g PO once
Microsporidium
- Albendazole 400mg PO BID x 21 days + HAART therapy if HIV positive
Cryptosporidium
- Paromomycin 500mg PO q8hrs x 14-28days +HAART therapy if HIV positive
Salmonella (non typhoid)
- Treatment is not recommended routinely but should be considered if:
- Immunocompromised
- Age<6 mo or >50yo
- Has any prostheses
- Valvular heart disease
- Severe Atherosclerosis
- Active Malignancy
- Uremic
Options: Immunocompromised patients should have 14 days of therapy
- TMP/SMX 1 DS tab PO BID x 5 days
- Ceftriaxone 2g IV once daily x 5 days
- Levofloxacin 500mg PO once daily x 5 days
- Ciprofloxacin 500mg PO BID x 5 days
Shigella
Treatment extended for 10 days if immunocompromised'
- Ciprofloxacin 500mg PO BID x 5 days
- TMP/SMX 1 DS tab PO BID x 5 days
- Levofloxacin 500mg PO once daily x 5 days
- Azithromycin 500mg PO daily x 5 days
Vibrio Cholerae
- Doxycycline 300mg PO as single dose
- TMP/SMX 1 tablet (5mg/kg) PO BID daily x 3 daily
- Azithromycin 20mg/kg (1g) PO once
Yersinia enterocolitica
Antibiotics are not required unless patient is immunocompromised or systemically ill
- Ciprofloxacin 500mg PO BID daily
- Levofloxacin 500mg PO once daily
- TMP/SMX 1 DS tab (5mg/kg) PO BID
Disposition
- Hospitalization should be individualized based on the patient's ability to tolerate oral hydration, have adequate social support, and also based on complicating comorbidities.
- Majority of patients can be treated as an ouptatient
- Observation or admission is required for those with severe disease, and significant dehydration with other end organ complications
See Also
References
- ↑ Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
- ↑ Aranda-Michel J et al. Acute diarrhea: A practical review. AmJMed. 1999;106:670-676.
- ↑ DuPont HL et al. Practice Parameters Committee of the American College of Gastroenterology. Guidelines on acute infectious diarrhea in adults. Am J Gastroenterol. 1997;92:1962-1975.
- ↑ IDSA Practice Guidelines for the Management of Infectious Diarrhea. 2001. fulltext
- ↑ Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5
- ↑ Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
- ↑ Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8
- ↑ Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
- ↑ Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
- ↑ DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15
- ↑ Stauffer WM, Konop RJ, Kamat D. Traveling with infants and young children. Part III: travelers’ diarrhea. J Travel Med. 2002;9:141–50